Mark D. Reeth, General Counsel&VP Corporate Compliance at SALIX PHARMACEUTICALS LTD (SLXP), sold 1,622 shares at $7.16 ($12K) on 2008-05-01, disclosed to the SEC on 2008-05-05.
Open-market sale of $12k SLXP by General Counsel&VP Corporate Compliance. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SLXP | SELL | 2011-05-17 | $135K | — | Filing → |
| SLXP | SELL | 2010-06-15 | $155K | — | Filing → |
| SLXP | SELL | 2010-05-19 | $126K | — | Filing → |